NO834792L - DNA SEQUENCES, PLASMIDS CONTAINING SUCH SEQUENCES, AND PROCEDURES FOR PREPARING SUCH SEQUENCES - Google Patents

DNA SEQUENCES, PLASMIDS CONTAINING SUCH SEQUENCES, AND PROCEDURES FOR PREPARING SUCH SEQUENCES

Info

Publication number
NO834792L
NO834792L NO83834792A NO834792A NO834792L NO 834792 L NO834792 L NO 834792L NO 83834792 A NO83834792 A NO 83834792A NO 834792 A NO834792 A NO 834792A NO 834792 L NO834792 L NO 834792L
Authority
NO
Norway
Prior art keywords
sequences
procedures
preparing
plasmids containing
sequence
Prior art date
Application number
NO83834792A
Other languages
Norwegian (no)
Other versions
NO173742C (en
NO173742B (en
Inventor
Marc-Bruce Dworkin
Eva Dworkin-Rastl
Guenther Adolf
Peter Meindl
Peter Swetly
Rudolf Hauptmann
Norbert Hauel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO834792L publication Critical patent/NO834792L/en
Publication of NO173742B publication Critical patent/NO173742B/en
Publication of NO173742C publication Critical patent/NO173742C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to the combination of the promoter/operator region of the tryptophan operon of Serratia marcescens with a synthetic ribosome binding sequence, an expression plasmid which contains this sequence and in which the above sequence is followed by the only Hind III cleavage site in the plasmid, into which site the gene to be expressed can be inserted, and to production plasmids for the expression of eukaryotic gene products in prokaryotes, especially for the preparation of leucocyte interferon.
NO834792A 1982-12-24 1983-12-23 Procedure for Preparation of an IFN-alpha Expression Plasmid and Polypeptide with IFN Activity NO173742C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247922 DE3247922A1 (en) 1982-12-24 1982-12-24 DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS

Publications (3)

Publication Number Publication Date
NO834792L true NO834792L (en) 1984-06-25
NO173742B NO173742B (en) 1993-10-18
NO173742C NO173742C (en) 1994-01-26

Family

ID=6181687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834792A NO173742C (en) 1982-12-24 1983-12-23 Procedure for Preparation of an IFN-alpha Expression Plasmid and Polypeptide with IFN Activity

Country Status (19)

Country Link
EP (1) EP0115613B1 (en)
JP (2) JPH088868B2 (en)
KR (1) KR930005455B1 (en)
AT (1) ATE62018T1 (en)
AU (1) AU579991B2 (en)
DD (1) DD216043A5 (en)
DE (2) DE3247922A1 (en)
DK (1) DK576983A (en)
ES (4) ES8501798A1 (en)
FI (1) FI86991C (en)
GR (1) GR78766B (en)
HU (1) HU202277B (en)
IL (1) IL70523A (en)
MX (1) MX9202878A (en)
NO (1) NO173742C (en)
NZ (1) NZ206700A (en)
SU (2) SU1366064A3 (en)
UA (1) UA8035A1 (en)
ZA (1) ZA839519B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE67786T1 (en) * 1984-08-01 1991-10-15 Boehringer Ingelheim Int NEW GENETIC SEQUENCES ENCODED BY TYPE I INTERFERON PEPTIDES AND THEIR PRODUCING ORGANISMS.
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
FI90990C (en) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Recombinant DNA molecule, transformed host organism, and method for producing interferon
DK151585D0 (en) * 1985-04-03 1985-04-03 Nordisk Gentofte DNA sequence
DK156072C (en) * 1985-04-03 1989-11-06 Nordisk Gentofte SYNTHETIC DNA SEQUENCE CONTAINING A RIBO BINDING SITE
DE3514113A1 (en) * 1985-04-19 1986-10-23 Hoechst Ag, 6230 Frankfurt CHANGE OF THE DNA SEQUENCE BETWEEN SHINE-DALGARNO SEQUENCE AND START CODON OF THE TRP OPERON TO INCREASE PROTEIN EXPRESSION
US4874703A (en) * 1985-08-26 1989-10-17 Eli Lilly And Company Expression vectors for use in E. coli
DE3607835A1 (en) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int HYBRID INTERFERONS, THEIR USE AS MEDICINAL PRODUCTS AND AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF ANTIBODIES AND THE USE THEREOF AND METHOD FOR THEIR PRODUCTION
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
AU4315089A (en) * 1988-11-04 1990-05-28 Upjohn Company, The Somatotropin expression using a serratia promoter
EP0626448A3 (en) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Process for preparing and purifying alpha-interferon
US5531880A (en) * 1994-09-13 1996-07-02 Microelectronics And Computer Technology Corporation Method for producing thin, uniform powder phosphor for display screens
FR2724665B1 (en) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa PROCESS FOR PRODUCING RECOMBINANT PROTEINS, PLASMIDS AND MODIFIED CELLS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
DE3280127D1 (en) * 1981-03-27 1990-04-12 Ici Plc GENETICALLY MODIFIED MICROORGANISMS.
DE3220116A1 (en) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach MICROBIOLOGICALLY MANUFACTURED (ALPHA) AND SS INTERFERONES, DNA SEQUENCES CODING FOR THESE INTERFERONES, MICROORGANISMS CONTAINING THIS GENETIC INFORMATION, AND METHOD FOR THE PRODUCTION THEREOF
DE3247923A1 (en) * 1982-12-24 1984-06-28 Dr. Karl Thomae Gmbh, 7950 Biberach Oligonucleotides and process for their preparation

Also Published As

Publication number Publication date
JPH088868B2 (en) 1996-01-31
ZA839519B (en) 1985-08-28
FI86991B (en) 1992-07-31
ES8506090A1 (en) 1985-06-16
SU1366064A3 (en) 1988-01-07
IL70523A0 (en) 1984-03-30
NO173742C (en) 1994-01-26
FI834700A (en) 1984-06-25
DD216043A5 (en) 1984-11-28
GR78766B (en) 1984-10-02
DE3382233D1 (en) 1991-05-02
AU2283283A (en) 1984-06-28
KR840007105A (en) 1984-12-05
SU1417800A3 (en) 1988-08-15
HU202277B (en) 1991-02-28
DE3247922A1 (en) 1984-06-28
NO173742B (en) 1993-10-18
EP0115613B1 (en) 1991-03-27
DK576983A (en) 1984-06-25
FI834700A0 (en) 1983-12-21
JPH05214000A (en) 1993-08-24
UA8035A1 (en) 1995-12-26
ATE62018T1 (en) 1991-04-15
ES528350A0 (en) 1984-12-01
AU579991B2 (en) 1988-12-22
IL70523A (en) 1991-08-16
JP2637328B2 (en) 1997-08-06
ES8504930A1 (en) 1985-04-16
MX9202878A (en) 1992-06-30
ES533197A0 (en) 1985-02-16
ES533213A0 (en) 1985-06-16
DK576983D0 (en) 1983-12-14
ES8501798A1 (en) 1984-12-01
JPS59162888A (en) 1984-09-13
EP0115613A3 (en) 1986-07-23
NZ206700A (en) 1987-11-27
EP0115613A2 (en) 1984-08-15
FI86991C (en) 1992-11-10
ES533214A0 (en) 1985-04-16
ES8503372A1 (en) 1985-02-16
KR930005455B1 (en) 1993-06-22

Similar Documents

Publication Publication Date Title
NO834792L (en) DNA SEQUENCES, PLASMIDS CONTAINING SUCH SEQUENCES, AND PROCEDURES FOR PREPARING SUCH SEQUENCES
EP0042246B1 (en) Plasmid
ES8207514A1 (en) Mature human leukocyte interferon A, process for its microbial preparation, intermediates therefor and compositions containing it.
DK440083A (en) DNA SEQUENCES, RECOMBINATION DNA MOLECULES, AND PROCEDURES FOR PREPARING PIG GROWTH HORMON-LIKE POLYPEPTIDES
ES8603574A1 (en) Production of polypeptides with a human gamma-interferon activity.
DE3666838D1 (en) Plasmid vectors for expression in escherichia coli and/or bacillus subtilis
MX9701614A (en) Method for the production of recombinant proteins, plasmids and modified cells.
DE3586473T2 (en) PLASMIDES CONTAINING THE LAMBDA PL PROMOTOR AND TECHNICAL PRODUCED RESTRICTION POINT FOR EASY REPLACEMENT OF A RIBOSOMAL BONDING POINT, THE PLASMIDE CONTAINERS AND PROCEDURES.
AU9026691A (en) New human recombinant gamma interferon
YU48371B (en) Plasmids They Obtain And Use Them To Obtain A Single Plasminogen Gene Activator
ZA81292B (en) Microbiologically prepared polypeptide with the aminoacid sequence of the proinsulin or primates,dna and plasmids which act as codings for this sequence,microorganisms which contain this genetic information,and processes for their preparation
ES8705921A1 (en) Production of human somatomedin c.
JPS57181098A (en) Novel recombinant dna
BG52178B2 (en) Method for chemical synthesis and expression of the gene of human noncystein -interferon
ES8704208A1 (en) New expression vectors contg. lambda p1 promoter